הכנסה לפני ניכוי ריבית, מסים ופחת: uniqure.com (QURE)
uniQure N.V. (QURE) maintains business resilience through a safe liquidity buffer and the development of new pipelines. The operating cash flow volume visualizes this trend, where the 0.00 mark serves as a key metric. Revenues rely on royalties from HEMGENIX sales via CSL Behring. Supply reliability is guaranteed by strict temperature controls and isolation during the transport of drugs to specialized centers.
uniQure - פילוחים אנליטיים ומדדי מפתח (QURE)
The investment attractiveness of uniQure N.V. (QURE) depends on its ability to generate internal resources amid biotech sector volatility. This metric measures the actual cash flow from core operations before interest and taxes, reflecting the fundamental efficiency of the business. By analyzing the operating cash result on GURU.Markets, an investor assesses the company's resilience to geopolitical risks and disruptions in European supply chains. Growth in this indicator confirms the ability to fund clinical trials without external borrowing. Stable positive dynamics guarantee capital preservation and long-term growth.
